Trial Profile
A pilot, randomised, double blind, placebo-controlled, parallel groups, clinical trial to investigate the efficacy and safety of Cardiotrophin-1 (CT-1) in kidney transplantation.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 18 Mar 2015
Price :
$35
*
At a glance
- Drugs Cardiotrophin 1 (Primary)
- Indications Ischaemia; Reperfusion injury
- Focus Therapeutic Use
- Sponsors Digna Biotech
- 18 Mar 2015 New trial record